Development of Peyer's patches, follicle-associated epithelium and M cell: Lessons from immunodeficient and knockout mice

Seminars in Immunology

Volumn 11, Issue 3, 1999, Pages 183-191

  Debard, Nathalie ^a   Sierro, Fréderic ^a   Kraehenbuhl, Jean Pierre ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Knockout mice; M cells; Mucosa associated lymphoid tissue; Organogenesis; Peyer's patch

Indexed keywords

CHEMOKINE RECEPTOR; LYMPHOTOXIN;

B LYMPHOCYTE; DEVELOPMENT; GENE DISRUPTION; IMMUNE DEFICIENCY; KNOCKOUT MOUSE; LYMPH NODE; LYMPHOID TISSUE; M CELL; PEYER PATCH; REVIEW;

EID: 0032792810     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1006/smim.1999.0174     Document Type: Article

References (61)

1. Hein WR. Organization of mucosal lymphoid tissue. Curr Top Microbiol Immunol. 236:1998;1.
2. Kraehenbuhl JP, Neutra MR. Defense of mucosal surfaces: pathogenicity, immunity and vaccines. Curr Topics Microbiol Immunol. 236:1998;1-246.
3. Neutra, MR, 1999.
4. Owen R. Uptake and transport of intestinal macromolecules and microorganisms by M cells in Peyer's patches- a personal and historic perspective. Sem Immunol, 1999.
5. Cebra, JJ, Jiang, HQ, Sterzl, J, Tlaskalova-Hogenova, H, 1998.
6. Gebert A, Pabst R. M cells location outside of the gut. Sem Immunol. 1999.
7. +cells w ith memory for intestinal rotavirus. J Clkin Invest. 100:1997;1204.
8. Corthésy B, Kraehenbuhl JP. Antibody-mediated protection of mucosal surfaces. Curr Top Microbiol Immunol. 236:1998;93.
9. MacDonald TT. Effector and regulatory lymphoid cells and cytokines in mucosal sites. Curr Top Microbiol Immunol. 236:1998;113.
10. Kanamori Y, Ishimaru K, Nanno M, Maki K, Ikuta K, Nariuchi H, Ishikawa H. Identification of novel lymphoid tissues in murine intestinal mucosa where clusters of c-kit +IL-7R+ Thy1+ lympho-hemopoietic progenitors develop. J Exp Med. 184:1996;1449.
11. Saito H, Kanamori Y, Takemori T, Nariuchi H, Kubota E, Takahashiiwanaga H, Iwanaga T, Ishikawa H. Generation of intestinal T cells from progenitors residing in gut cryptopatches. Science. 280:1998;275.
12. Shaw SK, Hermanowski-Vosatka A, Shibahara T, McCormick BA, Parkos CA, Carlson SL, Ebert EC, Brenner MB, Madara JL. Migration of intestinal intraepithelial lymphocytes into a polarized epithelial monolayer. Am J Physiol. 38:1998.
13. Sabin FR. Further evidence on the origin of the lymphatic endothelium from the endothelium of the blood vascular system. Anat Rec. 2:1908;46.
14. Yancopoulos GD, Klagsbrun M, Folkman J. Vasculogenesis, angiogenesis and growth factors: ephrins enter the fray at the border. Cell. 93:1998;661.
15. Lymboussaki A, Partanen TA, Olofsson B, Thomas-Crusells J, Fletcher CD, de Waal RM, Kaipainen A, Alitalo K. Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors. Am J Pathol. 153:1998;395.
16. Kukk E, Lymboussaki A, Taira S, Kaipainen A, Jeltsch M, Joukov V, Alitalo A. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development 122. 1996.
17. Eikelenboom P, Nassy JJ, Post J, Versteeg JC, Langevoort HL. The histogenesis of lymph nodes in rat and rabbit. Anat Rec. 190:1978;201.
18. Adachi S, Yoshida H, Kataoka H, Nishikawa S. Three distinctive steps in Peyer patch formation of murine embryo. Int Immunol. 9:1997;507.
19. -cells to colonize lymph nodes. Proc Natl Acad Sci (USA). 93:1996;11019.
20. -h ematolymphoid cells. Cell Adh Commun. 6:1998;97.
21. +cells that can differentiate to APC, NK Cells, and follicular cells but not T or B cells. Immunity. 7:1997;493.
22. Adachi S, Yoshida H, Honda K, Maki K, Saijo K, Ikuta K, Saito T, Nishikawa S. Essential role of IL-7 receptor alpha in the formation of Peyer's patch anlage. Int Immunol. 10:1998;1.
23. Nosaka T, Vandeursen JMA, Tripp RA, Thierfelder WE, Witthuhn BA, Mcmickle AP, Doherty PC, Grosveld GC, Ihle JN. Defective lymphoid development in mice lacking jak3. Science. 270:1995;800.
24. Korner H, Sedgwick JD. Tumour necrosis factor and lymphotoxin: molecular aspects and role in tissue-specific autoimmunity. Immunol Cell Biol. 74:1996;465.
25. Degli-Esposti MA, Davis-Smith T, Din WS, Smolak PJ, Goodwin RG, Smith CA. Activation of the lymphotoxin beta receptor by cross-linking induces chemokine production and growth arrest in A375 melanoma cells. Immunology. 158:1997;1756.
26. Zhai Y, Guo R, Hsu TL, Yu GL, Ni J, Kwon BS, Jiang GW, Lu J, Tan J, Ugustus M, Carter K, Rojas L, Zhu F, Lincoln C, Endress G, Xing L, Wang S, Oh KO, Gentz R, Ruben S, Lippman ME, Hsieh SL, Yang D. LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer. J Clin Invest. 102:1998;1142.
27. Kwon BS, Tan KB, Ni J, Oh KO, Lee ZH, Kim KK, Kim YJ, Wang S, Gentz R, Yu GL, Harrop J, Lyn SD, Silverman C, Porter TD, Truneh A, Young PR. A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation. J Biol Chem. 272:1997;14272.
28. Wong BR, Josien R, Lee SY, Sauter B, Li HL, Steinman RM, Choi YW. Trance (Tumor Necrosis Factor [Tnf]-Related Activation-Induced Cytokine), a New Tnf Family Member Predominantly Expressed in T Cells, Is a Dendritic Cell-Specific Survival Factor. J Exp Med. 186:1997;2075.
29. Anderson DM, Maraskovsky E, Billingsley WL, Dougall WC, Tometsko ME, Roux ER, Teepe MC, DuBose RF, Cosman D, Galibert L. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature. 390:1997;175.
30. Wong BR, Rho J, Arron J, Robinson E, Orlinick J, Chao M, Kalachikov S, Cayani E, Bartlett FS 3rd, Frankel WN, Lee SY, Choi Y. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J Biol Chem. 272:1997;25190.
31. DeTogni P, Goellner J, Ruddle NH, Streeter PR, Fick A, Mariathasan S, Smith SC, Carlson R, Shornick LP, Strauss-Schoenberger J, Russell JH, Karr R, Chaplin DD. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science. 264:1994;703.
32. Koni PA, Sacca R, Lawton P Browning JL, Ruddle NH, Flavell RA. Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin beta-deficient mice. Immunity. 6:1997;491.
33. Alimzhanov MB, Kuprash DV, Koscovilbois MH, Luz A, Turetskaya RL, Tarakhovsky A, Rajewsky K, Nedospasov SA, Pfeffer K. Abnormal development of secondary lymphoid tissues in lymphotoxin β-deficient mice. Proc Natl Acad Sci (USA). 94:1997;9302.
34. Rennert PD, Browning JL, Mebius R, Mackay F, Hochman PS. Surface lymphotoxin alpha/beta complex is required for the development of peripheral lymphoid organs. J Exp Med. 184:1996;1999.
35. Futterer A, Mink K, Luz A, Koscovilbois MH, Pfeffer K. The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity. 9:1998;59.
36. Neumann B, Luz A, Pfeffer K, Holzmann B. Defective Peyer's patch organogenesis in mice lacking the 55-kD receptor for tumor necrosis factor. J Exp Med. 184:1996;259.
37. Pasparakis M, Alexopoulou L, Grell M, Pfizenmaier K, Bluethmann H, Kollias G. Peyer's patch organogenesis is intact yet formation of B lymphocyte follicles is defective in peripheral lymphoid organs of mice deficient for tumor necrosis factor and its 55-Kda receptor. Proc Natl Acad Sci (USA). 94:1997;6319.
38. Korner H, Cook M, Riminton DS, Lemckert FA, Hoek RM, Ledermann B, Kontgen F, Destgroth BF, Sedgwick JD. Distinct Roles For Lymphotoxin-Alpha and Tumor Necrosis Factor in Organogenesis and Spatial Organization of Lymphoid Tissue. Eur J Immunol. 27:1997;2600.
39. Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S, Oliveira-dos-Santos AJ, Van G, Itie A, Khoo W, Wakeham A, Dunstan CR, Lacey DL, Mak TW, Boyle WJ, Penninger JM. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organo- genesis. Nature. 397:1999;315.
40. Koni PA, Flavell RA. A role for tumor necrosis factor receptor type 1 in gut-associated lymphoid tissue development: genetic evidence of synergism with lymphotoxin beta. J Exp Med. 187:1998;1977.
41. Cuff CA, Schwartz J, Bergman CM, Russell KS, Bender JR, Ruddle NH. Lymphotoxin alpha 3 induces chemokines and adhesion molecules: Insight into the role of LT alpha in inflammation and lymphoid organ development. J Immunol. 161:1998;6853.
42. Wagner N, Lohler J, Kunkel EJ, Ley K, Leung E, Krissansen G, Rajewsky K, Muller W. Critical role for beta-7 integrins in formation of the gut-associated lymphoid tissue. Nature. 382:1996;366.
43. Gunn MD, Ngo VN, Ansel KM, Ekland EH, Cyster JG, Williams LT. A B-cell-homing chemokine made in lymphoid follicles activates Burkitts-lymphoma receptor-1. Nature. 391:1998;799.
44. Förster R, Mattis AD, Kremmer E, Wolf E, Brem G, Lipp M. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatamic compartments of the spleen. Cell. 87:1996;1037.
45. Yokota Y, Mansouri A, Mori S, Sugawara S, Adachi S, Nishikawa SI, Gruss P. Developement of peripheral lympjhoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature. 397:1999;702.
46. Hiller AS, Tschernig T, Kleemann WJ, Pabst R. Bronchus-associated lymphoid tissue (BALT) and larynx-associated lymphoid tissue (LALT) are found at different frequencies in children, adolescents and adults. Scand J Immunol. 47:1998;159.
47. Schmidt GH, Wilkinson MM, Ponder BAJ. Cell migration pathway in the intestinal epithelium: an in situ marker system using mouse aggregation chimeras. Cell. 40:1985;425.
48. Hermiston, ML, Simon, TC, Crossman, MW, Gordon, JI, 1994.
49. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 119:1992;493.
50. Bye WA, Allan CH, Trier JS. Structure, distribution and origin of M cells in Peyer's patches of mouse Ileum. Gastroenterology. 86:1984;789.
51. Savidge TC, Smith MW. Mestecky J,. Evidence that membranous (M) cell genesis is immunoregulated, in Advances in mucosal immunology. 1995;239 Plenum, New York.
52. Kernéis S, Bogdanova A, Colucci-Guyon E, Kraehenbuhl JP, Pringault E. Cytosolic distribution of villin in M cells from mouse Peyer's patches correlates with the absence of a brush border. Gastroenterology. 110:1996;515.
53. Borghesi C, Regoli M, Bertelli E, Nicoletti C. Modifications of the follicle-associated epithelium by short-term exposure to a non-intestinal bacterium. J Pathol. 180:1996;326.
54. Giannasca PJ, Giannasca KT, Falk P, Gordon JI, Neutra MR. Regional differences in glycoconjugates of intestinal M cells in mice: potential targets for mucosal vaccines. Am J Physiol. 267:1994;1108.
55. Simon-Assmann P, Kedinger M. Heterotypic cellular cooperation in gut morphogenesis and differentiation. Semin Cell Biol. 4:1993;221.
56. El Bahi S, Caliot ME, Vandewalle A, Kahn A, Kraehenbuhl JP, Pringault E. Distinct promotors control expression in epithelial cells along the crypt-villus axis and in the follicle-associated lymphoid tissue. 1999.
57. Kernéis S, Bogdanova A, Kraehenbuhl JP, Pringault E. Conversion by Peyer's patch lymphocytes of human enterocytes into M cells that transport bacteria. Science. 277:1997;948.
58. Klinke S, Kernéis S, Schulte R, Bartels H, Preger S, Pringault E, Kraehenbuhl JP, Autenrieth IB. Conversion of Caco-2 cells into M cells causes the redistribution of the Yersinia enterolitica β1 intergrin receptor from the basolateral to the apical cell surface. 1999.
59. Kitamura D, Rajewsky K. Targeted disruption of mu chain membrane exon causes loss of heavy-chain allelic exclusion. Nature. 356:1992;154.
60. James PS, Rossetti C, Smith MW, Cremaschi D. Confocal microscopical analysis of epithelial cell heterogeneity in mouse Peyer' spatches. Histochem J. 24:1992;243.
61. Clark MA, Jepson MA, Simmons NL, Booth TA, Hirst BH. Differential expression of lectin-binding sites defines mouse intestinal M-cells. J Histochem Cytochem. 41:1993;1679.